LINK: https://bswhealth.webex.com/bswhealth/j.php?MTID=m7e6eab3b7a73125588e3c548816af4ec

OBJECTIVES: Upon completion of this activity, the participant should be able to:  (1) assess the efficacy of RIC for acute moderate ischemic stroke and (2) assess the efficacy of tDCS and FES for strength production in stroke patients.

FACULTY DISCLOSURE:  Ye Chu, DO and Matthew Shonnard, MD, MPH have no relevant financial relationship(s) with companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.

PLANNER DISCLOSURE: Rita Hamilton, DO and Mary Elizabeth Miller-Phillips, MD have no relevant financial relationship(s) to disclose with companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.

ACCREDITATION: The A. Webb Roberts Center for Continuing Medical Education of Baylor Scott & White Health is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

DESIGNATION:  The A. Webb Roberts Center for Continuing Medical Education of Baylor Scott & White Health designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit™.  Physicians should claim only the credit commensurate with the extent of their participation in the activity.

For information, please contact Taylor Anne Shafer at Taylor.Shafer@BSWHealth.org